From Coffee to Collaboration: Bringing ASCEND to Life with AMGEN
How ASCEND came to be and the instrumental role Amgen played to help shape this revolutionary platform for preclinical pharmaceutical research
How ASCEND came to be and the instrumental role Amgen played to help shape this revolutionary platform for preclinical pharmaceutical research
In partnering with industry-leading biotech research publisher Mary Ann Liebert, Inc., BenchSci continues to empower scientists in making discoveries with clinical benefits.
New BenchSci feature includes on- and off-target scores and off-target site sequences with highlighted mismatches for RNA-based reagents
We’ve added data from 20 million new protein experiments to our database, along with amino acid coordinates and protein structural data.
To evolve with the ever-changing biomedical research landscape, we added 3 new immunoassays to BenchSci: RUT&RUN, CITE-Seq, and REAP-Seq. Read on to find out more about these applications and how you can find the data on BenchSci!
To help scientists run more successful experiments, we added over 6.6 million CRISPR reagents from top vendors to our AI-Assisted Reagent Selection platform.
We launched several new features and date updates throughout Q1, 2020, including SARS-CoV-2 data, new filters, product comparison and export functions. Read the Q1 recap for more details!
To help scientists run more successful experiments, we added over 1.8 million protein products to our AI-Assisted Reagent Selection platform. Read on to find out how you can leverage these data.
Learn about how you can now search applications by acronyms and filter for additional antibody specifications on BenchSci!